Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Bartholomew J Tortella"'
Autor:
Michelle Witkop, Angela Lambing, Terry L. Anderson, Cynthia D. Nichols, James Munn, Bartholomew J Tortella
Publikováno v:
Patient Preference and Adherence. 13:1577-1587
Purpose Depression, anxiety, pain, and treatment adherence have reciprocal effects not characterized extensively in hemophilia. This study explored the relationships between depression, anxiety, chronic pain, and treatment adherence in adults with he
Autor:
Pablo Rendo, Kaan Kavakli, Marcus E. Carr, Lynne Smith, Bartholomew J Tortella, Joan M. Korth-Bradley
In a pivotal, multicenter, open-label study, 25 patients aged 12-54 years with moderately severe/severe hemophilia B received on-demand nonacog alfa (6 months; dose at investigator's discretion) followed by once-weekly prophylaxis with nonacog alfa 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae56f98e0083b772a756c01a839becc8
https://hdl.handle.net/11454/77394
https://hdl.handle.net/11454/77394
Autor:
Jonathan de Courcy, Emily Rubinstein, Dean Spurden, Jose Alvir, A Chhabra, Andreas M. Pleil, Bartholomew J Tortella, Simon Harris, Patrick F. Fogarty, Jennifer Mellor
Publikováno v:
Blood Coagul Fibrinolysis
Standard-of-care treatment for haemophilia A or B is to maintain adequate coagulation factor levels through clotting factor administration. The current study aimed to evaluate annualised bleeding rates (ABR) and treatment adherence for haemophilia A
Autor:
Cary Clark, Adrian Quartel, Crystal Watson, Donna Coffin, Johnny Mahlangu, Glenn F. Pierce, Brian O'Mahony, Mark W. Skinner, Ian Winburn, Eileen K Sawyer, Mayss Naccache, Steve Pipe, Bartholomew J Tortella, Alfonso Iorio, Lindsey A. George, Flora Peyvandi, Barbara A. Konkle
Publikováno v:
Haemophilia
Autor:
Margaret V. McDonald, Dean Spurden, Andreas M. Pleil, Patrick F. Fogarty, Bartholomew J Tortella, A Chhabra, Jose Alvir
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 24:643-653
Hemophilia B requires replacement therapy with factor IX (FIX) coagulation products to treat and prevent bleeding episodes. A recently introduced extended half-life (EHL) recombinant FIX replacement product provided the opportunity to compare the amo
Autor:
James Munn, Michelle Witkop, Bartholomew J Tortella, John M McLaughlin, Terry L. Anderson, Angela Lambing
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-9 (2017)
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes
Background Health-related quality of life (HRQoL) in adolescents and young adults with bleeding disorders is under-researched. We aimed to describe factors related to HRQoL in adolescents and young adults with hemophilia A or B or von Willebrand dise
Autor:
Maria del Carmen Rial, José Cruz, Bartholomew J Tortella, Alvaro Pacheco-Silva, Huihua Li, Helio Tedesco Silva, Pablo Cornicelli, Rodolfo Torres, Carlos Estevez
Publikováno v:
Transplantation proceedings. 52(3)
Sirolimus is approved for prophylaxis of organ rejection following renal transplantation. Rates of treatment-emergent adverse events (TEAEs) leading to sirolimus discontinuation differ geographically.Rates of TEAEs, serious AEs (SAEs), and discontinu
Autor:
Michelle L, Witkop, Angela, Lambing, Cynthia D, Nichols, James E, Munn, Terry L, Anderson, Bartholomew J, Tortella
Publikováno v:
Patient preference and adherence
Purpose Depression, anxiety, pain, and treatment adherence have reciprocal effects not characterized extensively in hemophilia. This study explored the relationships between depression, anxiety, chronic pain, and treatment adherence in adults with he
Autor:
Ramon Torres, Bartholomew J. Tortella, Mary Ann Sakmyster, Maureen McCormac, Eric Munoz, John W. Odom, Douglas S. Livornese
Publikováno v:
Health Policy and the Hispanic ISBN: 9780429034442
Health Policy and the Hispanic ISBN: 9780429034367
Health Policy and the Hispanic
Health Policy and the Hispanic ISBN: 9780429034367
Health Policy and the Hispanic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6088a2309d05a5f9eddcc485aff3ae8
https://doi.org/10.4324/9780429034442-10
https://doi.org/10.4324/9780429034442-10
Autor:
James Munn, Terry L. Anderson, Michelle Witkop, Bartholomew J Tortella, John M McLaughlin, Angela Lambing
Publikováno v:
Haemophilia. 22:e245-e250
Introduction Adherence to clotting-factor treatment regimens, especially among adolescents and young adults (AYAs), is under-researched. Aim We determined factors associated with better adherence to prophylaxis. Methods From April through December 20